Top Markets
Coin of the day
Impact BioMedical Inc. Impact BioMedical Inc.

Impact BioMedical Inc.

IBO
Hisse Senetlerindeki Sıralama #25450
Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on... Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions. Additionally, "Laetose" technology, a unique blend of sugar and inositol, is designed to counteract the inflammatory and metabolic responses usually triggered by sugar consumption. Impact BioMedical also creates "functional fragrance formulations," which are a series of fragrances incorporating specialized botanical ingredients for antimicrobial purposes, or as active additives in items like insect repellents, cleaning products, personal care items, and fabrics. Rounding out its offerings is the "Equivir/Equivir G" technology, a distinctive mix of polyphenols that has exhibited antiviral properties, suitable for use in health supplements and medications.
Hisse Fiyatı
$0.4587
Son senkronizasyon: 2026-08-20
Piyasa Değeri
$49.46M
Değişim (1 gün)
5.89%
Değişim (1 yıl)
-22.83%
Ülke
US
Ticaret Impact BioMedical Inc. (IBO)

Kategori

Impact BioMedical Inc. (IBO) için P/B oranı
2026 itibarıyla P/B oranı TTM: 0
Impact BioMedical Inc. şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/B oranı (TTM) 0'dir. 2026 yılının sonunda şirketin P/B oranı 0 idi.
Impact BioMedical Inc. için P/B oranı geçmişi 2026 - 2026 arası
Her yılın sonunda P/B oranı
Yıl P/B Oranı Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için P/B oranı
Şirket P/B Oranı P/B Oranı Farkı Ülke
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH
3.7087 -
US